SHS Capital, an independent private equity company focus on investments in the MedTech and Life Sciences sectors, completed the €18m investment in MESI Medical, the maker of MESI mTABLET, predictive medical assessment platform for healthcare with extensive AI and marketplace capabilities. “We are thrilled that our European and global efforts have resulted in a partnership with SHS. The aim of our innovation is to facilitate access to relevant diagnostic data. This speeds up the diagnostic process for the patient, resulting in faster treatment and prevention of adverse events. The SHS investment will allow us to continue developing new ways for healthcare professionals to predict, diagnose, and manage various conditions with greater accuracy and efficiency,” Jakob Šušterič, MESI CEO.